Our findings further revealed a novel mechanism underlying the anticancer effect of LPLUNC1 and clarified that PHB1 was a tumour suppressor in NPC and provide potential targets for NPC diagnosis and treatment. This evidence concerns the gene BPIFB1 and nasopharyngeal carcinoma.